Catalog No.
Product Name
Application
Product Information
Citations
-
Cannabinoid
O,O-Dimethyl-cannabigerol primarily targets cannabinoid receptors and is derived from Cannabis sativa. It exhibits antibacterial activity against drug-resistant strains of Staphylococcus aureus, demonstrating a minimum inhibitory concentration (MIC) of 1 to 2 μg/mL. As a nonpsychoactive constituent, O,O-Dimethyl-cannabigerol is valuable for research into therapeutic applications of cannabinoids, particularly in antimicrobial studies. -
Cannabinoid Receptor Agonist
AM9405 is a selective agonist for cannabinoid receptor type 1 (CB1) and serotonin type 3 (5-HT3) receptors. It demonstrates potent inhibitory effects on twitch contractions in the ileum and colon, with half-maximal inhibitory concentrations (IC50) of 45.71 nM and 0.076 nM, respectively. AM9405 is valuable for research in gastrointestinal motility and cannabinoid signaling pathways. -
Stable Isotope
Rimonabant-d10 hydrochloride is a deuterium-labeled derivative of Rimonabant hydrochloride, a selective antagonist of the central cannabinoid receptor (CB1) with a Ki of 1.8 nM. This compound is utilized in studies investigating the role of CB1 receptors in various physiological processes and the development of obesity therapies. Additionally, Rimonabant hydrochloride is known to inhibit Mycobacterial membrane protein Large 3 (MMPL3), making it relevant for research in tuberculosis and related infectious diseases. -
Phytocannabinoid Derivative
Cannabigerol diacetate is a phytocannabinoid derivative that modulates cannabinoid receptors in the endocannabinoid system. This compound exhibits potential anti-inflammatory and neuroprotective activities, making it an important tool for studying the therapeutic effects of cannabinoids. Its unique structural properties also allow for exploration in various research applications, including pain management and the effects of cannabinoids on neurological disorders. -
Cannabinoid Derivative
CH-FUBIATA is a synthetic cannabinoid derivative with a specific affinity for cannabinoid receptors. This compound demonstrates significant biological activity, impacting pathways involved in pain modulation, appetite regulation, and neuroprotection. CH-FUBIATA is applicable in research focusing on endocannabinoid system modulation, toxicological assessments, and the therapeutic potential of cannabinoids in various diseases. -
cannabinoid
Bzo-poxizid is a synthetic cannabinoid that primarily targets cannabinoid receptors in the central nervous system. This compound exhibits psychoactive properties, making it relevant for studies investigating endocannabinoid modulation and its effects on behavior. Bzo-poxizid may also be utilized in research applications focused on the therapeutic potential of cannabinoids in various neurological disorders. -
Cannabinoids Precursor
2-(2-Chlorophenyl)-1-(1H-indol-3-yl)ethanone is a key precursor in the synthesis of synthetic cannabinoids. This compound plays an essential role in the development of novel cannabinoid derivatives that may be used in pharmacological research. Its ability to modify cannabinoid structures makes it valuable for studies examining cannabinoid receptor interactions and their physiological effects. -
Cannabinoid-type Compounds
(±)-9-Nor-9α-hydroxy Hexahydrocannabinol is a cannabinoid-type compound that demonstrates significant cannabinoid-like activity in animal models, specifically in dogs and mice. This compound may be of interest for research exploring the therapeutic effects and pharmacological mechanisms of cannabinoids. Its efficacy in modulating cannabinoid receptors makes it a valuable tool for studies in areas such as pain relief, anxiety reduction, and other neuropsychopharmacological applications. -
Phytocannabinoid Metabolite
5'-Hydroxy-9(R)-hexahydrocannabinol is a phytocannabinoid metabolite that serves as a significant derivative of cannabinoids. It is known to exhibit potential psychoactive properties and interact with the endocannabinoid system. This compound may be utilized in research related to neuropharmacology, cannabinoid receptor studies, and the investigation of cannabis metabolites in biological systems. -
CB2 Receptor Ligand
Δ8-THC methyl ether is a selective ligand for the CB2 receptor, exhibiting a favorable docking score of -10.167 kcal/mol. This compound demonstrates significant antinociceptive activity in murine models, highlighting its potential for research in pain management and cannabinoid receptor studies. Further investigation into its pharmacological properties may support its application in the development of therapeutics targeting the endocannabinoid system. -
Cannabinoid Derivative
2-Fluoro QMPSB is a cannabinoid derivative that acts as a selective modulator of the cannabinoid receptors. This compound exhibits potent biological activity, making it useful for studying cannabinoid receptor mechanisms in research applications related to neuropharmacology and therapeutic developments. Its structural similarity to established synthetic cannabinoids provides valuable insights into cannabinoid receptor interactions and signaling pathways. -
Oxopyridine Carboxamide
CHO-4′Me-5′Br-FUBOXPYRA is an oxopyridine carboxamide that interacts with cannabinoid receptors CB1 and CB2. This compound exhibits limited activation potential, making it a valuable tool for studying the pharmacological properties of synthetic cannabinoids. Its unique structural features support research applications in cannabinoid receptor signaling and the development of cannabinoid-related therapies. -
Phytocannabinoid Derivative
(±)-9α-Hydroxy hexahydrocannabinol is a phytocannabinoid derivative that exhibits interactions with cannabinoid receptors in the endocannabinoid system. This compound has been explored for its potential therapeutic effects, including analgesic and anti-inflammatory properties. It serves as a valuable tool in research focused on understanding the pharmacological profiles of cannabinoids and their effects on various biological pathways. -
CB2 Receptor Agonist
PF-03550096 is an orally active synthetic cannabinoid that selectively targets peripheral CB2 receptors, exhibiting a Ki value of 7.9 nM. This compound demonstrates notable analgesic activity, making it useful for research applications related to pain modulation and inflammation. Its selective action on CB2 receptors enhances its potential for studying cannabinoid-based therapies in various physiological contexts. -
Cannabinoid Derivative
Afubiata is a cannabinoid derivative that interacts with the cannabinoid receptors in the endocannabinoid system. This compound exhibits potential biological activity related to modulating pain, inflammation, and neuroprotection. Afubiata is suitable for research applications focused on cannabinoid receptor mechanisms and the therapeutic effects of cannabinoids in various physiological processes. -
Phytocannabinoid Derivative
8(S)-Hydroxy-9(R)-hexahydrocannabinol is a phytocannabinoid derivative with a unique structural profile resembling known cannabinoids. This compound exhibits significant biological activity, including potential interaction with cannabinoid receptors, which makes it a valuable tool in cannabis research. It is applicable in studies investigating the therapeutic effects of cannabinoids, including pain relief and anti-inflammatory properties. -
Cannabinoid Derivative
(±)-9-Nor-9β-hydroxy Hexahydrocannabinol is a cannabinoid derivative that exhibits pronounced binding affinity for cannabinoid receptors. This compound is utilized in research to investigate the pharmacological effects of cannabinoids, including their influence on pain perception, appetite regulation, and neuroprotection. Its structural similarity to known synthetic cannabinoids makes it a valuable tool for studies focused on cannabinoid interactions and therapeutic potential. -
Cannabinoid Derivative
NAPIE is a cannabinoid derivative that modulates cannabinoid receptors. It exhibits significant biological activity in the endocannabinoid system, which is pivotal for studying the therapeutic potential of cannabinoids. NAPIE is primarily used in research applications related to neurobiology, pain management, and the exploration of cannabinoid signaling pathways. Its structural similarity to existing synthetic cannabinoids makes it a valuable tool for further investigations in cannabinoid biology. -
Cannabinoid Derivative
2-(1-(4-Fluorobenzyl)-1H-indol-3-yl)acetic acid is a cannabinoid derivative that interacts with cannabinoid receptors in the endocannabinoid system. This compound exhibits analgesic and anti-inflammatory properties, making it valuable for research in pain management and inflammation pathways. It serves as a useful tool in studying the pharmacological effects of cannabinoid-like substances. -
CB1/CB2 Agonist
PSB-SB1202 is a phenyl coumarin compound that acts as a dual agonist for the cannabinoid receptors CB1 and CB2. It demonstrates high biological activity with EC50 values of 56 nM for CB1 and 14 nM for CB2, alongside Ki values of 32 nM and 49 nM, respectively. This compound is suitable for research applications focused on the endocannabinoid system and its implications in various physiological processes. -
Δ9,11-THC Analogue
exo-Tetrahydrocannabivarin is a Δ9,11-THC analogue that demonstrates weak binding affinity for cannabinoid receptors (CB) with an IC50 of 1.4 μM. Its biological activity includes effects on motor functions and analgesia, as evidenced in preclinical models using mice. This compound is valuable for research investigating cannabinoid receptor interactions and their implications in pain management and motor control studies. -
Cannabinoid Receptor Antagonist
Giminabant is a cannabinoid receptor antagonist that primarily targets CB1 receptors. It has been shown to modulate endocannabinoid signaling, making it a useful compound for studying metabolic diseases and addiction-related disorders. Its application in research may provide insights into therapeutic approaches for obesity and substance dependence. -
Phytocannabinoid Derivative
Δ8-THCPA-A is a derivative of Δ8-Tetrahydrocannabiphorolic acid, designed to modulate cannabinoid receptors due to its structural similarities to known phytocannabinoids. This compound exhibits significant biological activity, contributing to research on the endocannabinoid system and its implications in therapeutic applications. It serves as a valuable tool for exploring the pharmacological effects and potential medicinal uses of cannabinoids in various biomedical studies. -
Phytocannabinoid Metabolite
Carmagerol is a phytocannabinoid metabolite that interacts with the endocannabinoid system, primarily influencing cannabinoid receptor activity. It exhibits potential neuroprotective and anti-inflammatory properties, making it a valuable compound for research into its effects on pain management and neurological disorders. Carmagerol can be utilized in studies investigating the therapeutic applications of cannabinoids and their metabolites in various biological models. -
Phytocannabinoid Derivative
8(R)-Hydroxy-9(R)-hexahydrocannabinol is a phytocannabinoid derivative that acts as a metabolite of 9(R)-Hexahydrocannabinol. This compound exhibits notable biological activities related to cannabinoid receptor modulation, which may be relevant for studies on cannabinoid pharmacology. It is primarily utilized in research focusing on the therapeutic potential of cannabinoids in various physiological and pathological processes. -
Phytocannabinoid Metabolite
(±)-8'-Hydroxy cannabichromene is a phytocannabinoid metabolite that acts on the endocannabinoid system. It exhibits potential biological activity by interacting with cannabinoid receptors, which may influence various physiological processes. This compound is primarily utilized in research applications focused on cannabis pharmacology, cannabinoid receptor signaling, and the therapeutic effects of cannabinoids. -
Cannabinoid Derivative
5-Fluoro PB-22 N-(2-fluoropentyl) isomer is a synthetic cannabinoid derivative that selectively targets cannabinoid receptors. This compound exhibits potent agonistic activity, making it valuable for research into cannabinoid receptor signaling pathways and their physiological effects. Its unique structure allows for the exploration of cannabinoid-related research applications, including studies related to neuropharmacology and the endocannabinoid system. -
Phytocannabinoid
Tetrahydrocannabiphorol (THCP) is a phytocannabinoid that exhibits potent binding affinity for cannabinoid receptors, specifically CB1 and CB2. This compound has been shown to possess significant analgesic and anti-inflammatory properties, making it a valuable tool for researching pain management and therapeutic applications related to cannabinoid signaling pathways. THCP is of interest in studies examining the efficacy of cannabinoids in various health conditions and may offer insights into the pharmacological potential of cannabis-derived compounds. -
CB1 Agonist
AM11542 is a selective orthosteric agonist of cannabinoid receptor 1 (CB1), exhibiting a reported binding affinity (Ki) of 0.11 nM. This compound facilitates the study of CB1 receptor activation and provides insights into the mechanisms of allosteric modulation. Its application is valuable in exploring the physiological roles of CB1 in various biological pathways and potential therapeutic targets in cannabinoid research. -
Biochemical Reagent
CH-PIATA is a synthetic cannabinoid characterized by an acetamide linker, serving as a biochemical reagent in research applications. This compound exhibits potential biological activity, with EC50 values of >71 nM and >176 nM for cannabinoid receptors CB1 and CB2, respectively. CH-PIATA can be effectively detected as a parent substance in biological samples, making it a useful tool for studying cannabinoid receptor interactions and their physiological roles. -
Phytocannabinoid Derivative
Δ9-Tetrahydrocannabiorcol is a phytocannabinoid derivative that exhibits structural similarity to established cannabinoids. This compound has been studied for its interactions with the endocannabinoid system, demonstrating potential effects on cannabinoid receptors. It serves as a valuable research tool for exploring the therapeutic applications of cannabinoids in areas such as pain management, neuroprotection, and inflammation. -
Phytocannabinoid Derivative
Δ9-THCH is a phytocannabinoid derivative that exhibits structural similarities to established cannabinoids. This compound interacts with the endocannabinoid system, demonstrating potential biological activity relevant to pain modulation and inflammation reduction. Research applications include studies on cannabinoid receptor signaling and the investigation of therapeutic effects in various neurobiological contexts. -
Cannabinoid Derivative
CHM-FUBIATA is a synthetic cannabinoid derivative that acts primarily on the cannabinoid receptors. It exhibits notable affinity for these receptors, leading to significant alterations in neurotransmitter release and neuroprotection. This compound is utilized in research focused on understanding the pharmacological effects of cannabinoids and their potential therapeutic applications in various neurological disorders. -
Cannabinoid Derivative
PB-22 N-Pentanoic acid-3-carboxyindole metabolite is a significant metabolite of the cannabinoid PB-22, primarily interacting with cannabinoid receptors. This compound exhibits notable activity in modulating cannabinoid signaling pathways and can be utilized in research applications focused on the effects of cannabinoids in neuropharmacology, pain management, and potential therapeutic interventions for various disorders related to the endocannabinoid system. Its study can enhance the understanding of cannabinoid metabolism and its biological implications. -
CB1 Inverse Agonist
MRL-650 is a potent inverse agonist of the CB1 receptor, exhibiting an IC50 of 7.5 nM for CB1, while maintaining a significantly lower affinity for the CB2 receptor at 4100 nM. This compound is orally active and is primarily utilized in research focused on anorexigenic effects. Its selectivity and potency make MRL-650 a valuable tool for investigating the physiological and pharmacological roles of the endocannabinoid system. -
Phytocannabinoid Derivative
iso-Hexahydrocannabinol is a phytocannabinoid derivative that interacts with the endocannabinoid system, primarily targeting cannabinoid receptors. Its unique structure allows it to exhibit biological activities similar to those of other cannabinoids, making it a valuable tool in research exploring the effects of cannabinoids on various physiological processes. Applications include studies on pain management, neuroprotection, and potential therapeutic effects in various medical conditions. -
Phytocannabinoid Derivative
Δ8-iso-THC is a phytocannabinoid derivative that exhibits structural similarities to established cannabinoids. This compound engages cannabinoid receptors, demonstrating potential modulating effects on the endocannabinoid system. Δ8-iso-THC is useful for research into its therapeutic applications, including pain relief, anti-inflammatory effects, and potential neuroprotective properties. Its unique chemical structure makes it a valuable reagent for studying cannabinoid pharmacology and related therapeutic areas. -
Cannabinoid
3-CAF is a synthetic cannabinoid that targets the cannabinoid receptor pathway. This compound exhibits significant activity in modulating cannabinoid receptor signaling, making it a valuable tool for investigating cannabinoid-related biological processes. Its unique 3-carboxylate-indazole structure enhances its selectivity and potency, supporting research applications in pharmacology and neurobiology focused on cannabinoid interactions and their physiological effects. -
Phytocannabinoid Derivative
Cannabigerorcinic acid is a phytocannabinoid derivative that exhibits structural similarities to well-characterized cannabinoids. This compound has demonstrated potential biological activity, making it a valuable asset in the study of cannabinoid mechanisms and their physiological effects. It is particularly relevant for research focusing on the endocannabinoid system, cannabinoid receptor interactions, and potential therapeutic applications in various disorders. -
Cannabinoid Receptor
Cannabiorcol, a cannabinoid receptor modulator, exhibits structural similarities to well-characterized phytocannabinoids. This compound has shown potential in influencing cannabinoid receptor activity, making it a valuable tool in cannabinoid research. Its biological activity is relevant for studies investigating the pharmacological effects of cannabinoids and therapeutic applications in various physiological conditions. -
BB-22 Analog
Methyl-1-(cyclohexylmethyl)-1H-indole-3-carboxylate is an analog of BB-22, characterized by the absence of the quinoline moiety. This compound engages cannabinoid receptors, contributing to its potential as a research tool in pharmacological studies. Its unique structure supports investigations into cannabinoid signaling pathways and may aid in understanding the effects of synthetic cannabinoids. This reagent is suitable for applications in drug discovery and development within the cannabinoid research field. -
Cannabinoid Derivative
5-Fluoro PB-22 5-hydroxyquinoline isomer is a synthetic cannabinoid derivative that acts primarily on cannabinoid receptors. This compound exhibits potent agonistic activity, making it valuable for research into cannabinoid receptor signaling and the pharmacological effects of synthetic cannabinoids. Its use in studies can provide insights into therapeutic applications and the modulation of endocannabinoid system functions. -
THJ-018 Derivative
5-Fluoro THJ is a derivative of the synthetic cannabinoid THJ-018, targeting cannabinoid receptors in the endocannabinoid system. It exhibits biological activity that may influence neurochemical signaling and has potential applications in cannabinoid research, pharmacology, and the study of psychoactive effects. Researchers can utilize this compound to explore the mechanisms underlying cannabinoid receptor activation and its implications in various physiological processes. -
Semisynthetic Cannabinoid
Δ8-THCP (Δ8-Tetrahydrocannabiphorol; n-Heptyl Δ8-THC) is a semisynthetic cannabinoid that primarily targets the CB1 receptor. It has been identified as an analytical reference standard and demonstrates significant affinity for this receptor, contributing to its potential biological activities. This compound is useful in various research applications, particularly in studies focused on cannabinoid receptor interactions and their effects. -
Cannabinoid Receptor Antagonist
CB1 Antagonist 1 is a selective antagonist of the cannabinoid receptor 1 (CB1). It plays a crucial role in research pertaining to metabolic syndrome and obesity, as well as various neuroinflammatory, cognitive, and gastrointestinal disorders. Additionally, it is valuable for investigating cardiovascular conditions, making it a versatile tool in the study of endocannabinoid system-related pathways. -
CB1 Antagonist
Monlunabant is a selective antagonist of the cannabinoid receptor 1 (CB1) with an inhibitory constant (Ki) of 0.3 nM for human CB1 receptors, and 613 nM for human CB2 receptors. This compound demonstrates potent activity in modulating cannabinoid signaling pathways, making it a valuable tool for researching the roles of CB1 in various physiological processes. Its applications include the exploration of metabolic disorders, neurodegenerative diseases, and potential therapeutic interventions involving the endocannabinoid system. -
CB1R Positive Allosteric Modulator
CB1R Allosteric Modulator 3 is a positive allosteric modulator targeting the CB1 receptor. It exhibits potent inhibition of cyclic AMP (cAMP) and β-Arrestin with EC50 values of 0.018 μM and 1.241 μM, respectively. This compound is valuable for research applications focused on understanding cannabinoid receptor signaling and its implications in various physiological processes. -
Cannabinoid Receptor Agonist
2-Arachidonoylglycerol is a potent agonist of cannabinoid receptors, primarily targeting CB1 and CB2 receptors in the central nervous system. It plays a crucial role in various physiological processes, including pain modulation, appetite control, and neuroprotection. 2-Arachidonoylglycerol is widely used in research applications investigating the endocannabinoid system and its implications in neurobiology, pharmacology, and therapeutic development. -
Biochemical Assay Reagent
ACEA (arachidonyl-2'-chloroacetamide) is a synthetic compound that acts as an agonist of the cannabinoid receptor CB1. It modulates the endocannabinoid system, influencing physiological processes including appetite regulation, pain perception, mood, and memory. This biochemical assay reagent is essential for research exploring the pharmacological effects and therapeutic potential of cannabinoid signaling. -
Insecticide
S-Methoprene is an insect juvenile hormone analog that functions as an effective insecticide by disrupting the transformation from pupa to adult stage in insects. Additionally, S-Methoprene acts as a ligand for the CB(1) receptor, inhibiting the binding of the CB1 receptor antagonist [3H]CP-55940 with an IC50 of 19.31 μM. This compound is valuable in research applications focused on pest control and the mechanisms of cannabinoid receptor interactions.
